{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AYI/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T02:34:49.681Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8957,"canonical_name":"ACUITY INC. (DE)","cik":"0001144215","uei":null,"lei":null,"duns":null,"ticker":"AYI"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":16},"count":16,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"3","title":"3 — ACUITY INC. (DE) — 2026-10-05","url_slug":"/sec/cik-0001144215/3/0002006945-26-000005","accession_number":"0002006945-26-000005","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"8-K","title":"8-K — ACUITY INC. (DE) — 2026-10-01","url_slug":"/sec/cik-0001144215/8-k/0001144215-26-000047","accession_number":"0001144215-26-000047","importance":35},{"ts":"2026-09-29","kind":"sec.filing","form_type":"8-K","title":"8-K — ACUITY INC. (DE) — 2026-09-29","url_slug":"/sec/cik-0001144215/8-k/0001104659-26-111917","accession_number":"0001104659-26-111917","importance":35},{"ts":"2026-09-28","kind":"sec.filing","form_type":"3","title":"3 — ACUITY INC. (DE) — 2026-09-28","url_slug":"/sec/cik-0001144215/3/0001891538-26-000014","accession_number":"0001891538-26-000014","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"4","title":"4 — ACUITY INC. (DE) — 2026-09-28","url_slug":"/sec/cik-0001144215/4/0001891538-26-000015","accession_number":"0001891538-26-000015","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — ACUITY INC. (DE) — 2026-09-03","url_slug":"/sec/cik-0001144215/4/0001302261-26-000008","accession_number":"0001302261-26-000008","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — ACUITY INC. (DE) — 2026-09-01","url_slug":"/sec/cik-0001144215/144/0001964306-26-000420","accession_number":"0001964306-26-000420","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — ACUITY INC. (DE) — 2026-07-06","url_slug":"/sec/cik-0001144215/4/0001790061-26-000002","accession_number":"0001790061-26-000002","importance":30},{"ts":"2026-07-02","kind":"sec.form144","reporter":"GOLDMAN BARRY R","title":"Officer","shares":1200,"usd_value":438780,"security_title":"Common Stock","approx_sale_date":"2026-07-02","accession_number":"0001964306-26-000309","importance":40.087756},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"GOLDMAN BARRY R","title":"SVP & General Counsel","shares":1200,"price_per_share":365.65,"usd_value":438780,"security_title":"Common Stock","importance":35.43878},{"ts":"2026-07-02","kind":"sec.filing","form_type":"144","title":"144 — ACUITY INC. (DE) — 2026-07-02","url_slug":"/sec/cik-0001144215/144/0001964306-26-000309","accession_number":"0001964306-26-000309","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"11-K","title":"11-K — ACUITY INC. (DE) — 2026-06-26","url_slug":"/sec/cik-0001144215/11-k/0001144215-26-000040","accession_number":"0001144215-26-000040","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — ACUITY INC. (DE) — 2026-06-03","url_slug":"/sec/cik-0001144215/4/0001302261-26-000006","accession_number":"0001302261-26-000006","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"HOLCOM KAREN J","title":"Officer","shares":2076,"usd_value":629319,"security_title":"Common Stock","approx_sale_date":"2026-06-01","accession_number":"0001964306-26-000261","importance":40.125863728},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"HOLCOM KAREN J","title":"SVP & Chief Financial Officer","shares":2076,"price_per_share":303.14,"usd_value":629319,"security_title":"Common Stock","importance":35.62931864},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — ACUITY INC. (DE) — 2026-06-01","url_slug":"/sec/cik-0001144215/144/0001964306-26-000261","accession_number":"0001964306-26-000261","importance":30}]}